Sarepta Therapeutics (NASDAQ:SRPT) 
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. The company offers EXONDYS 51 injection to treat duchenne muscul...
Website: http://www.sarepta.com
Founded: 1980
Full Time Employees: 743
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 59.42
H 59.45
L 54.26
C 54.43
V 4,575,815
10EMA 54.43
20EMA 54.43
60EMA 54.43
120EMA 54.43
250EMA 54.43